Hospital and Physician Variability in Revascularization Decisions and Outcomes for Patients With 3-Vessel and Left Main Coronary Artery Disease: A Population-Based Cohort Study

被引:0
作者
Wilson, Todd [1 ,2 ,4 ]
James, Matthew T. [1 ,2 ,4 ]
Southern, Danielle [6 ]
Har, Bryan [3 ,4 ]
Graham, Michelle M. [5 ]
Brass, Neil [7 ]
Bainey, Kevin [5 ]
Fedak, Paul W. M. [3 ,4 ]
Sajobi, Tolulope T. [2 ,4 ]
Wilton, Stephen B. [2 ,3 ,4 ]
机构
[1] Univ Calgary, Dept Med, Calgary, AB, Canada
[2] Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada
[3] Univ Calgary, Dept Cardiac Sci, Calgary, AB, Canada
[4] Univ Calgary, CanadaLibin Cardiovasc Inst, Calgary, AB, Canada
[5] Univ Alberta, Mazankowski Alberta Heart Inst, Edmonton, AB, Canada
[6] Univ Calgary, Ctr Hlth Informat, Cumming Sch Med, Calgary, AB, Canada
[7] Univ Alberta, CKHui Heart Ctr, Edmonton, AB, Canada
来源
JOURNAL OF THE AMERICAN HEART ASSOCIATION | 2024年 / 13卷 / 18期
关键词
coronary artery disease; death; practice variation; revascularization; NEW-YORK-STATE; SURGERY; INTERVENTION; VALIDATION;
D O I
10.1161/JAHA.123.035356
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Hospital- and physician-level variation for selection of percutaneous coronary intervention versus coronary artery bypass grafting (CABG) for patients with coronary artery disease has been associated with outcome differences. However, most studies excluded patients treated medically.Methods and Results From 2010 to 2019, adults with 3-vessel or left main coronary artery disease at 3 hospitals (A, B, C) in Alberta, Canada, were categorized by treatment with medical therapy, percutaneous coronary intervention, or CABG. Multilevel regression models determined the proportion of variation in treatment attributable to patient, physician, and hospital factors, and survival models assessed outcomes including death and major adverse cardiovascular events over 5 years. Of 22 580 patients (mean age, 67 years; 80% men): 6677 (29%) received medical management, 9171 (41%) percutaneous coronary intervention, and 6732 (30%) CABG. Hospital factors accounted for 10.8% of treatment variation. In adjusted models (site A as reference), patients at sites B and C had 49% (95% CI, 44%-53%) and 43% (95% CI, 37%-49%) lower rates of medical therapy, respectively, and 31% (95% CI, 24%-38%) and 32% (95% CI, 24%-40%) lower rates of CABG. During 5.0 years median follow-up, 3287 (14.6%) patients died, with no intersite mortality differences. There were no between-site differences in acute coronary syndromes or stroke; patients at sites B and C had 24% lower risk (95% CI, 13%-34% and 11%-35%, respectively) of heart failure hospitalization.Conclusions Hospital-level variation in selection of percutaneous coronary intervention, CABG, or medical therapy for patients with complex coronary artery disease was not associated with differences in 5-year mortality rates. Research and quality improvement initiatives comparing revascularization practices should include medically managed patients.
引用
收藏
页数:11
相关论文
共 50 条
  • [31] Ten-Year All-Cause Death According to Completeness of Revascularization in Patients With Three-Vessel Disease or Left Main Coronary Artery Disease Insights From the SYNTAX Extended Survival Study
    Takahashi, Kuniaki
    Serruys, Patrick W.
    Gao, Chao
    Ono, Masafumi
    Wang, Rutao
    Thuijs, Daniel J. F. M.
    Mack, Michael J.
    Curzen, Nick
    Mohr, Friedrich-Wilhelm
    Davierwala, Piroze
    Milojevic, Milan
    Wykrzykowska, Joanna J.
    de Winter, Robbert J.
    Sharif, Faisal
    Onuma, Yoshinobu
    Head, Stuart J.
    Kappetein, Arie Pieter
    Morice, Marie-Claude
    Holmes, David R., Jr.
    [J]. CIRCULATION, 2021, 144 (02) : 96 - 109
  • [32] Genetic, sociodemographic, lifestyle, and clinical risk factors of recurrent coronary artery disease events: a population-based cohort study
    Cho, So Mi Jemma
    Koyama, Satoshi
    Honigberg, Michael C.
    Surakka, Ida
    Haidermota, Sara
    Ganesh, Shriienidhie
    Patel, Aniruddh P.
    Bhattacharya, Romit
    Lee, Hokyou
    Kim, Hyeon Chang
    Natarajan, Pradeep
    [J]. EUROPEAN HEART JOURNAL, 2023, 44 (36) : 3456 - 3465
  • [33] The risk of coronary artery disease in patients with rheumatoid arthritis using Chinese herbal products and conventional medicine in parallel: a population-based cohort study
    Yu, Han-Hua
    Hsiung, Nai-Huan
    Chiang, Jen-Huai
    Shen, Hsuan-Shu
    [J]. BMC COMPLEMENTARY MEDICINE AND THERAPIES, 2020, 20 (01) : 100
  • [34] The risk of coronary artery disease in patients with rheumatoid arthritis using Chinese herbal products and conventional medicine in parallel: a population-based cohort study
    Han-Hua Yu
    Nai-Huan Hsiung
    Jen-Huai Chiang
    Hsuan-Shu Shen
    [J]. BMC Complementary Medicine and Therapies, 20
  • [35] Conservative Approach versus Percutaneous Coronary Intervention in Patients with Spontaneous Coronary Artery Dissection from a National Population-Based Cohort Study
    Krittanawong, Chayakrit
    Rodriguez, Beatriz Castillo
    Ang, Song Peng
    Qadeer, Yusuf Kamran
    Wang, Zhen
    Alam, Mahboob
    Sharma, Samin
    Jneid, Hani
    [J]. REVIEWS IN CARDIOVASCULAR MEDICINE, 2024, 25 (11)
  • [36] Exposure to Proton Pump Inhibitors and the Risk of Incident Asthma in Patients with Coronary Artery Diseases: A Population-Based Cohort Study
    Lin, Tsung-Kun
    Tsai, Chin-Feng
    Huang, Jing-Yang
    Pan, Lung-Fa
    Jong, Gwo-Ping
    [J]. JOURNAL OF PERSONALIZED MEDICINE, 2022, 12 (05):
  • [37] Long-term outcomes of percutaneous versus surgical revascularization in patients with diabetes and left main coronary artery disease: A meta-analysis of randomized controlled trials
    Carvalho, Pedro E. P.
    Veiga, Thiago M. A.
    Machado, Felipe S. L.
    Porto, Gabriel, V
    Pirez, Jacqueline
    Rivera, Manuel
    Melo, Pedro C.
    Braghiroli, Joao
    Cardoso, Rhanderson
    [J]. JOURNAL OF CARDIAC SURGERY, 2022, 37 (12) : 4646 - 4653
  • [38] Real-life characteristics and outcomes of patients who undergo percutaneous coronary intervention versus coronary artery bypass grafting for left main coronary artery disease: data from the prospective Multi-vessel Coronary Artery Disease (MULTICAD) Israeli Registry
    Ram, Eilon
    Goldenberg, Ilan
    Kassif, Yigal
    Segev, Amit
    Lavee, Jacob
    Einhorn-Cohen, Michal
    Raanani, Ehud
    [J]. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2018, 54 (04) : 717 - 723
  • [39] Lower Global Strain Predicts Left Main and Multi-Vessel Coronary Artery Disease in Asymptomatic Diabetic Patients. Factor 64 Study
    Rosen, Boaz
    Horton, Kenneth D.
    Balling, Kyle D.
    May, Heidi T.
    Lima, Joao A.
    Lappe, Donald L.
    Anderson, Jeffrey L.
    Muhlestein, Joseph B.
    [J]. CIRCULATION, 2012, 126 (21)
  • [40] Long-Term Outcomes of Stents vs. Bypass Surgery in Diabetic and Nondiabetic Patients with Multivessel and/or Left Main Coronary Artery Disease: Data From a Large Three-Observational Cohort Study
    Park, Duk-Woo
    Kim, Yong-Giun
    Park, Gyung-Min
    Hwang, Ki Won
    Kwon, Chang Hee
    Jang, Jeong Yoon
    Choi, Suk-Won
    Song, Hae-Geun
    Ahn, Jung-Min
    Kim, Won-Jang
    Lee, Jong-Young
    Kang, Soo-Jin
    Lee, Seung-Whan
    Kim, Young-Hak
    Lee, Cheol Whan
    Park, Seong-Wook
    Park, Seung-Jung
    [J]. CIRCULATION, 2011, 124 (21)